Atrás
Rango del Día
$9.20
$9.67
Rango de 52 Semanas
$3.30
$12.41
Volumen
431,888
Promedio 50D / 200D
$9.83
/
$8.38
Cierre Anterior
$9.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.8 | 0.4 |
| P/B | 2.6 | 2.9 |
| ROE % | -35.7 | 3.7 |
| Net Margin % | -391.0 | 3.8 |
| Rev Growth 5Y % | 8.6 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 8.55% annually over 5 years — modest growth
Earnings declined -1339.94% over the past year
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -175.95M
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 77.58%
Crecimiento
Revenue Growth (5Y)
8.55%
Revenue (1Y)-69.03%
Earnings (1Y)-1339.94%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-35.65%
ROIC-26.93%
Net Margin-390.95%
Op. Margin-371.65%
Seguridad
Debt / Equity
0.03
Current Ratio11.72
Interest Coverage-197.41
Valoración
P/E Ratio
-6.76
P/B Ratio2.63
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -69.03% | Revenue Growth (3Y) | -5.46% |
| Earnings Growth (1Y) | -1339.94% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8.55% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 48.27M | Net Income (TTM) | -188.69M |
| ROE | -35.65% | ROA | -33.57% |
| Gross Margin | 100.00% | Operating Margin | -371.65% |
| Net Margin | -390.95% | Free Cash Flow (TTM) | -175.95M |
| ROIC | -26.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 11.72 |
| Interest Coverage | -197.41 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.76 | P/B Ratio | 2.63 |
| P/S Ratio | 26.42 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.27B | Enterprise Value | 944.81M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48.27M | 155.84M | 54.00M | 172.83M | 34.76M |
| Net Income | -188.69M | 15.22M | -96.99M | 37.51M | -95.06M |
| EPS (Diluted) | -1.54 | 0.14 | -1.20 | 0.54 | -1.51 |
| Gross Profit | 48.27M | 155.84M | -64.67M | 66.05M | -52.81M |
| Operating Income | -179.38M | -38.62M | -101.73M | 29.95M | -86.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 562.10M | 696.15M | 509.97M | 407.82M | 174.65M |
| Total Liabilities | 78.20M | 121.30M | 284.88M | 194.66M | 150.58M |
| Shareholders' Equity | 483.89M | 574.84M | 225.08M | 213.16M | 24.06M |
| Total Debt | 15.63M | 16.20M | 15.40M | 14.56M | 9.85M |
| Cash & Equivalents | 345.77M | 236.75M | 218.47M | 148.52M | 132.99M |
| Current Assets | 503.79M | 629.56M | 449.37M | 377.15M | 152.21M |
| Current Liabilities | 42.99M | 67.99M | 156.55M | 106.45M | 95.15M |